Hypomethylation at other IFN-stimulated genes, such as IFI44 and IFITM1, in B cells also discriminates SLE patients from healthy controls, providing further evidence that DNA methylation around IFN-stimulated genes is a promising biomarker for SLE [12]. Here, IFNA1 is linked to systemic lupus erythematosus.